No Data
No Data
No Data
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup
Health-care companies rose after a surprising new entrant in the obesity-drug bonanza from one biotech giant. Amgen shares surged after the biotech giant said it saw encouraging signs from its inject
Dow JonesMay 3 16:51 ET
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
Wall Street's major indexes all jumped on the heels of a softer-than-expected jobs report released Friday by the US Department of Labor. In company news, Apple (AAPL) reported fiscal Q2 diluted earnin
MT NewswiresMay 3 12:14 ET
Catalent, Novo Nordisk Antitrust Review Extended by FTC
Catalent (CTLT) said Friday the US Federal Trade Commission is asking for more information while the agency reviews the proposed acquisition of the biologics and gene therapies company by Danish drug
MT NewswiresMay 3 10:12 ET
UPDATE 1-US FTC Seeks More Information on Novo Nordisk Parent-Catalent Deal
Yahoo FinanceMay 3 08:36 ET
Express News | Catalent Inc - Catalent and Novo Holdings Expect to Close Merger Towards End of Calendar Year 2024
ReutersMay 3 08:06 ET
Express News | Catalent Inc - Intend to Continue to Cooperate With FTC in an Effort to Obtain Antitrust Regulatory Clearance for Merger as Expeditiously as Possible
ReutersMay 3 08:05 ET